Purchase Order 75N93019P00923
Award Date
8/6/19
Potential Completion Date
8/7/20
Potential Value
$24K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Stemcell Technologies Inc.
Ultimate Awardee
Not listed
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a foreign-owned for-profit organization, to provide EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits. The total potential value of the award is $99,317.40. This was a sole-source procurement made under the authority of FAR 13.106-1, as the agency determined Stemcell Technologies Inc. was...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Stemcell Technologies Inc. for EASYSEP NEGATIVE HUMAN CD4 KITS. The $59,775.00 contract has a completion date of July 31, 2019 and was awarded on July 19, 2018 with no set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,670.00 firm fixed price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for CD4 EASYSEP NEGATIVE SELECTION KITS. This award was not set aside for any particular business type. Stemcell Technologies Inc. is an experienced federal contractor that frequently provides specialized biological materials, lab supplies, scientific...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The $6,699 firm fixed-price contract is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research, particularly in areas like immunology and infectious disease investigations....
This is a $17,134.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of EasySep Negative Human CD4 Kits, which are used in cell separation and cell culture applications to support biomedical research. The contract is a Blanket Purchase Agreement (BPA) call, meaning it is part of a larger indefinite...
This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subagency of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc. on June 13, 2016. The contract, with a ceiling value of $24,134.75, is for the delivery of EasySep kits, which are specialized cell separation and isolation products used in biomedical research. Stemcell Technologies Inc. is a Canadian biotechnology company that serves as...
This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the delivery of EasySep Enrichment Kits, which are specialized cell separation products used in biomedical research, particularly for studies in areas like stem cell research, immunology, cancer, and infectious diseases. The...